Not Yet Recruiting
Bevacizumab in Post-acute Sequelae of COVID-19 : Efficacy and Safety (Pilot Study)
NCT07089719
- Conditions
- COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
- Locations
-
- HEGP, clinical investigation center Paris, France
- HEGP, department of Physiology Paris, France